LMAT logo

LMAT Lemaitre Vascular Inc

$81.52
$0.70
(0.87%)
Today
Closed $81.52
$0.00
(0.00%)
After Hours
39

Bearish Sentiment

How do you feel about LMAT?

Loading...
PAHC or LMAT: Which Is the Better Value Stock Right Now?
PAHC vs. LMAT: Which Stock Is the Better Value Option?
Zacks
Reminder - LeMaitre Vascular (LMAT) Goes Ex-Dividend Soon
Looking at the universe of stocks we cover at Dividend Channel, on 8/20/26, LeMaitre Vascular Inc (Symbol: LMAT) will trade ex-dividend, for its quarterly dividend of $0.25, payable on 9/3/26. As a percentage of LMAT's recent stock price of $82.75, this dividend works out to ap...
Nasdaq News: Markets
GEHC or LMAT: Which Is the Better Value Stock Right Now?
GEHC vs. LMAT: Which Stock Is the Better Value Option?
Zacks
LeMaitre Vascular (LMAT) Hit by Profit Taking
LeMaitre Vascular (LMAT) Hit by Profit Taking...
Yahoo! Finance: News
LeMaitre Vascular (LMAT) Q2 Earnings and Revenues Lag Estimates
LeMaitre (LMAT) delivered earnings and revenue surprises of -8.64% and -1.91%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Boston Scientific (BSX) Surpasses Q2 Earnings and Revenue Estimates
Boston Scientific (BSX) delivered earnings and revenue surprises of +3.61% and +1.07%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Casey's & 3 More Stocks With Strong Interest Coverage to Buy Now
CASY, CLS, PNTG and LMAT stand out for strong interest coverage as borrowing costs rise, with solid sales/EPS growth estimates and big one-year gains.
Zacks
LeMaitre (LMAT) is an Incredible Growth Stock: 3 Reasons Why
LeMaitre (LMAT) possesses solid growth attributes, which could help it handily outperform the market.
Zacks
Down 17.2% in 4 Weeks, Here's Why LeMaitre (LMAT) Looks Ripe for a Turnaround
LeMaitre (LMAT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Zacks